山西普德药业有限公司
Clinical Trials
0
Active:0
Completed:0
Trial Phases
0 Phases
Drug Approvals
289
NMPA:289
Drug Approvals
Bortezomib for Injection
- Product Name
- 注射用硼替佐米
- Approval Number
- 国药准字H20253217
- Approval Date
- Jan 14, 2025
NMPA
Potassium Chloride Granules
- Product Name
- 氯化钾颗粒
- Approval Number
- 国药准字H20249672
- Approval Date
- Dec 1, 2024
NMPA
Roxatidine Acetate Hydrochloride for Injection
- Product Name
- 注射用盐酸罗沙替丁醋酸酯
- Approval Number
- 国药准字H20249167
- Approval Date
- Oct 22, 2024
NMPA
Compound Potassium Hydrogen Phosphate Injection
- Product Name
- 复合磷酸氢钾注射液
- Approval Number
- 国药准字H20094204
- Approval Date
- Oct 11, 2024
NMPA
Dipotassium Hydrogen Phosphate
- Product Name
- 磷酸氢二钾
- Approval Number
- 国药准字H20090368
- Approval Date
- Oct 11, 2024
NMPA
Iron Sucrose for Injection
- Product Name
- 注射用蔗糖铁
- Approval Number
- 国药准字H20090367
- Approval Date
- Oct 11, 2024
NMPA
Potassium Dihydrogen Phosphate
- Product Name
- 磷酸二氢钾
- Approval Number
- 国药准字H20090369
- Approval Date
- Oct 11, 2024
NMPA
Voriconazole for Injection
- Product Name
- 注射用伏立康唑
- Approval Number
- 国药准字H20244553
- Approval Date
- Jul 30, 2024
NMPA
Ropivacaine Mesylate for Injection
- Product Name
- 注射用甲磺酸罗哌卡因
- Approval Number
- 国药准字H20090271
- Approval Date
- Jun 26, 2024
NMPA
Ropivacaine Hydrochloride Injection
- Product Name
- 盐酸罗哌卡因注射液
- Approval Number
- 国药准字H20193218
- Approval Date
- Jun 26, 2024
NMPA
- Prev
- 1
- 2
- 3
- 4
- 5
- 29
- Next
Clinical Trials
No trials found
News
No news found